Kos Statin/Niacin Fixed Dose Combo To Be Supported By NHLBI-Funded Trial
This article was originally published in The Tan Sheet
Executive Summary
The National Heart, Lung & Blood Institute will provide more than $20 mil. in funding for a clinical study comparing a simvastatin/niacin combination therapy to simvastatin alone for prevention of cardiovascular events
You may also be interested in...
Niaspan/Statin Combinations Improve Lipid Control, Study Says
Data from a Phase IV efficacy trial of Kos' Niaspan, presented at the International Symposium on Atherosclerosis June 20 in Rome, supports the value of adding niacin to statin therapy for the treatment of high cholesterol, the company reported
Niaspan/Statin Combinations Improve Lipid Control, Study Says
Data from a Phase IV efficacy trial of Kos' Niaspan, presented at the International Symposium on Atherosclerosis June 20 in Rome, supports the value of adding niacin to statin therapy for the treatment of high cholesterol, the company reported
Niaspan/Statin Combinations Improve Lipid Control, Study Says
Data from a Phase IV efficacy trial of Kos' Niaspan, presented at the International Symposium on Atherosclerosis June 20 in Rome, supports the value of adding niacin to statin therapy for the treatment of high cholesterol, the company reported